Total Payments
$2,161
2024 Payments
$986.19
Companies
22
Transactions
87
Medicare Patients
884
Medicare Billing
$96,681
Payment Breakdown by Category
Food & Beverage$2,161 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,161 | 87 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $722.68 | 31 | $0 (2024) |
| QOL Medical, LLC | $289.92 | 10 | $0 (2024) |
| Madrigal Pharmaceuticals | $168.32 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $123.65 | 6 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $97.04 | 3 | $0 (2021) |
| Janssen Biotech, Inc. | $90.31 | 5 | $0 (2024) |
| GENZYME CORPORATION | $80.32 | 3 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $79.87 | 3 | $0 (2024) |
| Ardelyx, Inc. | $78.34 | 4 | $0 (2024) |
| ERBE USA Inc | $75.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $986.19 | 37 | ABBVIE INC. ($385.27) |
| 2023 | $749.90 | 34 | ABBVIE INC. ($282.43) |
| 2022 | $327.70 | 13 | ERBE USA Inc ($75.00) |
| 2021 | $97.04 | 3 | BOSTON SCIENTIFIC CORPORATION ($97.04) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: LIVER DISEASE | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $2.80 | General |
| 11/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $28.35 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $138.29 | General |
| Category: LIVER DISEASE | ||||||
| 09/11/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: Neuroscience | ||||||
| 09/04/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Gastroenterology | ||||||
| 08/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/13/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $32.74 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: GI | ||||||
| 06/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/19/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Rare Disease | ||||||
| 06/03/2024 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.64 | General |
| 05/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $30.51 | General |
| Category: IMMUNOLOGY | ||||||
| 05/08/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Immunology | ||||||
| 05/01/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 712 | 796 | $234,160 | $78,105 |
| 2022 | 10 | 172 | 195 | $50,588 | $18,575 |
Total Patients
884
Total Services
991
Medicare Billing
$96,681
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 87 | 88 | $46,024 | $16,685 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 150 | $27,300 | $9,734 | 35.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 99 | 100 | $28,200 | $7,350 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 71 | $18,176 | $6,493 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $16,900 | $5,953 | 35.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 37 | $14,763 | $4,940 | 33.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 64 | 64 | $26,240 | $4,821 | 18.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 76 | $10,944 | $4,670 | 42.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 44 | $12,012 | $4,544 | 37.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 18 | 18 | $6,822 | $3,199 | 46.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $7,959 | $2,678 | 33.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $7,264 | $2,548 | 35.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 19 | $3,914 | $1,643 | 42.0% |
| 43252 | Microscopic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $4,128 | $1,525 | 36.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $3,514 | $1,323 | 37.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $8,379 | $3,282 | 39.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $8,112 | $3,092 | 38.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 35 | $5,040 | $1,964 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 19 | $4,864 | $1,906 | 39.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $4,794 | $1,615 | 33.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $4,540 | $1,562 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 20 | $3,640 | $1,354 | 37.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $4,920 | $1,335 | 27.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 16 | $3,296 | $1,290 | 39.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,003 | $1,176 | 39.2% |
About Dr. Joseph Obi, M.D
Dr. Joseph Obi, M.D is a Gastroenterology healthcare provider based in Bradenton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2016. The National Provider Identifier (NPI) number assigned to this provider is 1497117253.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Obi, M.D has received a total of $2,161 in payments from pharmaceutical and medical device companies, with $986.19 received in 2024. These payments were reported across 87 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,161).
As a Medicare-enrolled provider, Obi has provided services to 884 Medicare beneficiaries, totaling 991 services with total Medicare billing of $96,681. Data is available for 2 years (2022–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Bradenton, FL
- Active Since 03/22/2016
- Last Updated 04/18/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1497117253
Products in Payments
- CREON (Drug) $340.53
- Sucraid (Drug) $163.14
- LINZESS (Drug) $145.28
- RINVOQ (Biological) $142.57
- REZDIFFRA (Drug) $138.29
- DUPIXENT (Biological) $131.52
- SUCRAID (Drug) $126.78
- GENERAL HEMOSTASIS (Device) $97.04
- XIFAXAN (Drug) $84.47
- ZEPOSIA (Drug) $78.78
- IBSRELA (Drug) $78.34
- VIO3 (Device) $75.00
- REMICADE (Biological) $69.90
- GATTEX (Drug) $58.77
- VOWST (Biological) $42.64
- TRULANCE (Drug) $39.18
- SKYRIZI (Biological) $30.51
- RESMETIROM (Drug) $30.03
- HUMIRA (Biological) $24.58
- VEGZELMA (Biological) $22.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Bradenton
Dr. Manuel Rodriguez, M.d, M.D
Gastroenterology — Payments: $66,652
Gastroenterology $66,652
Rimantas Zalepuga, Md, MD
Gastroenterology — Payments: $33,114
Gastroenterology $33,114
Mark Dawson
Gastroenterology — Payments: $9,050
Gastroenterology $9,050
Dr. John Roddenberry, M.d, M.D
Gastroenterology — Payments: $8,269
Gastroenterology $8,269
Michael Papper, M.d, M.D
Gastroenterology — Payments: $8,078
Gastroenterology $8,078
Dr. Michael Caire, Md, MD
Gastroenterology — Payments: $5,952
Gastroenterology $5,952